Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

When EBV was first identified: a tumour in Uganda and a virus under a microscope

Last reviewed November 15, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

EBV was the first virus ever shown to be linked to a human cancer, and it was found because a surgeon in Uganda noticed that a childhood tumour followed the map of malaria.

Here is how the virus was found, named, and slowly connected to the diseases it causes.

Related pages: Epstein-Barr virus (EBV) infection

The bottom line

What we know
  • The virus was seen under an electron microscope in February 1964 by Anthony Epstein, Bert Achong and Yvonne Barr.
  • It was the first virus linked to a human tumour.
  • Its link to mono was established in 1968 by Gertrude and Werner Henle, partly by accident.
What is still open
  • How much credit each person involved should receive. Yvonne Barr's and Bert Achong's roles were long under-recognized.

The timeline

  1. 1. 1958: Uganda (Denis Burkitt)
  2. 2. 1961: The lecture (Anthony Epstein)
  3. 3. 1964: The discovery (Anthony Epstein, Bert Achong and Yvonne Barr)
  4. 4. 1966 to 1968 (Gertrude and Werner Henle)
  5. 5. 1970 onward (Many research groups)
  6. 6. 2022 (Bjornevik and colleagues; Lanz and colleagues)
Moment 1 of 6

A surgeon notices a childhood tumour with a geography

Denis BurkittKampala, Uganda

What happened

Burkitt, an Irish surgeon working in Uganda, described a jaw tumour in African children and mapped where cases occurred.

What was found

  • The tumour followed a belt across Africa that matched areas of heavy rainfall and warmth.
  • That pattern looked like something transmitted, which suggested an infectious cause.
  • The map in fact matched malaria, which is now understood to weaken immune control of EBV.

Why it matters

A geographic map of a cancer was the clue that sent researchers looking for a virus. That was a radical idea at the time.

What's debated

  • Burkitt's early reasoning pointed at an insect-borne cause, which turned out not to be the mechanism.

Read more

Next: 1961: The lecture

Moment 2 of 6

Epstein hears Burkitt speak and changes his career

Anthony EpsteinMiddlesex Hospital, London

What happened

Epstein attended a lecture Burkitt gave in London in 1961 about the tumour.

What was found

  • Epstein proposed that the tumour was caused by a virus, and dropped his work on chicken tumour viruses to look for it.
  • Tumour samples were flown from Kampala to London in culture fluid.
  • Standard tests for known viruses came back negative, again and again, for more than two years.

Why it matters

The search depended on a guess that most of the field considered unfashionable: that a virus could cause a human cancer.

Read more

Next: 1964: The discovery

Moment 3 of 6

Herpes-like particles in a Burkitt lymphoma cell

Anthony Epstein, Bert Achong and Yvonne BarrLondon

What happened

Barr managed to keep tumour cells alive in suspension culture, a first for this kind of human cell. Achong and Epstein examined them with an electron microscope.

What was found

  • In February 1964, one of the cells contained particles that looked like a herpesvirus.
  • The findings were published in the Lancet that year as 'Virus particles in cultured lymphoblasts from Burkitt's lymphoma'.
  • It was the first demonstration of virus particles in a human tumour.
  • The cell line was called EB1, which is where the virus's name comes from.

Why it matters

This opened the entire field of human tumour viruses, which later led to the HPV vaccine among other things.

What's debated

  • Acceptance was slow. The finding was resisted for years before EBV was recognized as a human tumour virus.

Read more

Next: 1966 to 1968

Moment 4 of 6

The Henles name it, then find what it really causes

Gertrude and Werner HenleChildren's Hospital of Philadelphia

What happened

The Henles confirmed the new virus was unlike any known herpesvirus, named it the Epstein-Barr virus after the cell line, and began testing who had antibodies to it.

What was found

  • Antibodies to the virus turned out to be present in most healthy adults, which was confusing for a supposed cancer virus.
  • The breakthrough came when a laboratory technician who had tested negative caught mono, and afterwards tested positive.
  • In 1968 they published the link between the virus and infectious mononucleosis.

Why it matters

The same virus found in a rare African cancer turned out to be the cause of a common illness among Western teenagers, and to be carried by nearly everybody.

What's debated

  • The accidental nature of the key observation is a reminder of how much of this depended on luck and on careful record-keeping.

Read more

Next: 1970 onward

Moment 5 of 6

The list of linked diseases grows

Many research groups

What happened

Once tests existed, researchers looked for EBV in other conditions.

What was found

  • EBV DNA was found in nasopharyngeal carcinoma tissue in 1970.
  • In the 1980s it was linked to lymphomas and oral hairy leukoplakia in people with AIDS, and to disease after organ transplant.
  • The pattern in each case was the same: the virus is everywhere, but disease appears when immune control is lost.

Why it matters

EBV became the standard example of a virus whose harm depends on the state of the host, not the arrival of the germ.

What's debated

  • Association was often easier to show than causation, and some proposed links have not held up.

Read more

Next: 2022

Moment 6 of 6

The MS case is finally made

Bjornevik and colleagues; Lanz and colleaguesScience and Nature

What happened

Two studies published within weeks of each other transformed a decades-old suspicion into a strong case.

What was found

  • Stored blood from 10 million US military recruits showed MS risk rose 32-fold after EBV infection, and almost nobody developed MS without it.
  • A separate team showed that an antibody from the spinal fluid of MS patients binds both the EBV protein EBNA1 and a brain protein, GlialCAM.
  • Antibodies reacting to both were found in 20% to 25% of MS patients across three groups.

Why it matters

Nearly 60 years after it was first seen under a microscope, EBV was shown to be the trigger for a major human disease that it had never been suspected of when it was found.

What's debated

  • EBV is necessary but not sufficient for MS. Almost everyone carries the virus and very few get MS.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.